Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors

Abstract

Cyclooxygenase-2 (COX-2) inhibitors are widely used for the treatment of pain and inflammatory disorders such as rheumatoid arthritis and osteoarthritis. A series of novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives has been reported as COX-2 inhibitors. In order to understand the structural requirement of these COX-2 inhibitors, a ligand-based pharmacophore and atom-based 3D-QSAR model have been developed. A five-point pharmacophore with four hydrogen bond acceptors (A) and one hydrogen bond donor (D) was obtained. The pharmacophore hypothesis yielded a 3D-QSAR model with good partial least-square (PLS) statistics results. The training set correlation is characterized by PLS factors (r (2) = 0.642, SD = 0.65, F = 82.7, P = 7.617 e - 12). The test set correlation is characterized by PLS factors (Q (2) (ext) = 0.841, RMSE = 0.24,Pearson-R = 0.91). A docking study revealed the binding orientations of these inhibitors at active site amino acid residues (Arg513, Val523, Phe518, Ser530, Tyr355, His90) of COX-2 enzyme. The results of ligand-based pharmacophore hypothesis and atom-based 3D-QSAR give detailed structural insights as well as highlights important binding features of novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as COX-2 inhibitors which can provide guidance for the rational design of novel potent COX-2 inhibitors.

Combinatorial Pharmacophore Modeling and Atom Based 3d Qsar Studies of Benzothiadiazines as HCV-Ns5b Inhibitors

“…For a model generation, the entire data set was divided into a training set (70%) and test set (30%) in a random manner using "Automated Random Selection" option available in PHASE module [18]. PHASE has two approaches for building 3D-QSAR model-pharmacophore based and atom based approach.…”

Ligand Based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies to Design Novel Pancreatic Lipase Inhibitors

“…Conformers with a higher value than this threshold energy were discarded. All distances between pairs of corresponding heavy atoms were kept below 1.00 Å for two conformers to be considered identical [21]. In the pharmacophore creating step, each ligand structure is represented by a set of points in 3D space, which coincide with various chemical features that may facilitate non-covalent binding between the compound and its target receptor.…”

“…Focusing only on those pharmacophore models whose scores ranked in the top 1% [21], the most predictive QSAR model was found to be associated with the five point hypothesis AAAHH (Three hydrogen bond acceptor and two hydrophobic functions). The pharmacophoric inter sites distance and angles are shown in fig.…”

Discovery of Some Potent PDHK Inhibitors Using Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies

“…These CPHs were then examined using a scoring function in the "Score Hypotheses" panel to yield the best alignment of the active ligands [23] . We performed atom-based 3D-QSAR, as it takes into account the entire molecular structure [23][24][25][26] . We evaluated the best scoring hypothesis [27,28] by generating training and test sets using K-means clustering [29,30] .…”